Table 4 Signature comparing controls with cases disease-free in the follow-up. Final model
From: Circulating miRNAs signature on breast cancer: the MCC-Spain project
miRNA | TMM controls* | TMM cases* | P-value* | Fold change* | Odds ratio (95% CI)** | P** |
|---|---|---|---|---|---|---|
miR-101-3p | 1.959 | 1.558 | 8*10^-5 | 0.757 | 0.79 (0.48, 1.30) | 0.35 |
miR-423-3p | − 1.283 | − 1.037 | 0.003 | 1.186 | 1.97 (1.13, 3.44) | 0.02 |
miR-142-3p | 2.918 | 3.230 | 0.0002 | 1.242 | 1.55 (0.89, 2.71) | 0.12 |
miR-186-5p | − 3.510 | − 3.892 | 0.0006 | 0.768 | 0.60 (0.38, 0.97) | 0.04 |
miR-1299 | − 6.386 | − 6.052 | 0.008 | 1.26 | 1.65 (1.06, 2.55) | 0.03 |